A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)
Clinical trial NCT00000968 · COMPLETED
Trial details
- NCT number
- NCT00000968
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.